Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LLY.DE Stock Summary
Top 10 Correlated ETFs
LLY.DE
In the News
LLY.DE Financial details
Company Rating
Strong Buy
Market Cap
494.11B
Income
6.5B
Revenue
29.52B
Book val./share
12.3
Cash/share
3.14
Dividend
4.37
Dividend %
0.79%
Employees
39K
Optionable
No
Shortable
Yes
Earnings
02 Nov 2023
P/E
76.23
Forward P/E
48.77
PEG
53.27
P/S
17.71
P/B
44.77
P/C
164.81
P/FCF
162.74
Quick Ratio
0.63
Current Ratio
1.13
Debt / Equity
1.7
LT Debt / Equity
1.64
-
-
EPS (TTM)
7.03
EPS next Y
10.61
EPS next Q
-
EPS this Y
12.68%
EPS next Y
50.93%
EPS next 5Y
50.93%
EPS last 5Y
17.15%
Revenue last 5Y
5.84%
Revenue Q/Q
19.43%
EPS Q/Q
38.03%
-
-
-
-
SMA20
2.95%
SMA50
30.02%
SMA100
34.36%
Inst Own
-
Inst Trans
-
ROA
12%
ROE
60%
ROC
0.21%
Gross Margin
78%
Oper. Margin
25%
Profit Margin
22%
Payout
59%
Shs Outstand
949.29M
Shs Float
897.49M
-
-
-
-
Target Price
-
52W Range
289.85-565.0
52W High
-8.41%
52W Low
+79.07%
RSI
51
Rel Volume
0.55
Avg Volume
1.96K
Volume
1.09K
Perf Week
-3.45%
Perf Month
3.19%
Perf Quarter
53.74%
Perf Half Y
66.43%
-
-
-
-
Beta
0.315006
-
-
Volatility
6.42%, 17.44%
Prev Close
-0.58%
Price
517.5
Change
-0.58%
LLY.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 20.91 | 23.97 | 27.04 | 31.22 | 31.65 | |
Net income per share | 3.14 | 4.98 | 6.82 | 6.15 | 6.93 | |
Operating cash flow per share | 5.38 | 5.19 | 7.16 | 8.01 | 7.86 | |
Free cash flow per share | 2.44 | 3.74 | 4.93 | 5.94 | 5.1 | |
Cash per share | 7.21 | 2.62 | 4.06 | 4.31 | 2.45 | |
Book value per share | 9.56 | 2.8 | 6.22 | 9.9 | 11.81 | |
Tangible book value per share | 8.25 | -8.16 | -5.94 | -2.68 | -0.56 | |
Share holders equity per share | 9.56 | 2.8 | 6.22 | 9.9 | 11.81 | |
Interest debt per share | 10.29 | 17.4 | 18.68 | 18.99 | 18.38 | |
Market cap | 117.89B | 122.01B | 152.56B | 251.44B | 330.55B | |
Enterprise value | 120.87B | 135.48B | 165.5B | 264.51B | 344.72B | |
P/E ratio | 36.48 | 26.31 | 24.63 | 45.05 | 52.93 | |
Price to sales ratio | 5.48 | 5.47 | 6.22 | 8.88 | 11.58 | |
POCF ratio | 21.34 | 25.23 | 23.47 | 34.63 | 46.66 | |
PFCF ratio | 47.04 | 35.03 | 34.13 | 46.67 | 71.85 | |
P/B Ratio | 11.99 | 46.8 | 27.04 | 28 | 31.04 | |
PTB ratio | 11.99 | 46.8 | 27.04 | 28 | 31.04 | |
EV to sales | 5.62 | 6.07 | 6.74 | 9.34 | 12.08 | |
Enterprise value over EBITDA | 12.53 | 20.51 | 21.66 | 30.27 | 36.54 | |
EV to operating cash flow | 21.88 | 28.01 | 25.46 | 36.43 | 48.66 | |
EV to free cash flow | 48.22 | 38.9 | 37.02 | 49.1 | 74.93 | |
Earnings yield | 0.03 | 0.04 | 0.04 | 0.02 | 0.02 | |
Free cash flow yield | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | |
Debt to equity | 1.05 | 6.06 | 2.94 | 1.88 | 1.52 | |
Debt to assets | 0.23 | 0.4 | 0.36 | 0.35 | 0.33 | |
Net debt to EBITDA | 0.31 | 2.04 | 1.69 | 1.5 | 1.5 | |
Current ratio | 1.73 | 1.16 | 1.4 | 1.23 | 1.05 | |
Interest coverage | 22.74 | 12.42 | 16.85 | 18.71 | 21.49 | |
Income quality | 1.71 | 0.58 | 1.05 | 1.3 | 1.13 | |
Dividend Yield | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Payout ratio | 0.72 | 0.52 | 0.43 | 0.55 | 0.57 | |
Sales general and administrative to revenue | 0.28 | 0.28 | 0.25 | 0.23 | 0.23 | |
Research and developement to revenue | 0.24 | 0.25 | 0.25 | 0.25 | 0.25 | |
Intangibles to total assets | 0.06 | 0.26 | 0.24 | 0.24 | 0.23 | |
Capex to operating cash flow | -0.55 | -0.28 | -0.31 | -0.26 | -0.35 | |
Capex to revenue | -0.14 | -0.06 | -0.08 | -0.07 | -0.09 | |
Capex to depreciation | -1.88 | -1.1 | -1.53 | -1.21 | -1.63 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 26.01 | 17.71 | 30.89 | 37.03 | 42.9 | |
ROIC | 0.26 | 0.23 | 0.23 | 0.22 | 0.24 | |
Return on tangible assets | 0.08 | 0.16 | 0.17 | 0.15 | 0.16 | |
Graham Net | -19.18 | -30.5 | -32.99 | -30.55 | -30.97 | |
Working capital | 8.66B | 1.93B | 4.98B | 3.4B | 896.3M | |
Tangible asset value | 8.47B | -7.6B | -5.39B | -2.43B | -504.2M | |
Net current asset value | -12.45B | -22.88B | -23.35B | -21.2B | -20.68B | |
Invested capital | 1.05 | 6.06 | 2.94 | 1.88 | 1.52 | |
Average receivables | 5.52B | 5.66B | 6.24B | 7.53B | 8.34B | |
Average payables | 1.31B | 1.31B | 1.51B | 1.64B | 1.8B | |
Average inventory | 3.78B | 3.14B | 3.59B | 3.93B | 4.1B | |
Days sales outstanding | 98.1 | 90.62 | 103.06 | 104.75 | 109.45 | |
Days payables outstanding | 94.11 | 108.64 | 106.95 | 83.38 | 106.29 | |
Days of inventory on hand | 241.54 | 246.68 | 264.95 | 193.96 | 237.27 | |
Receivables turnover | 3.72 | 4.03 | 3.54 | 3.48 | 3.33 | |
Payables turnover | 3.88 | 3.36 | 3.41 | 4.38 | 3.43 | |
Inventory turnover | 1.51 | 1.48 | 1.38 | 1.88 | 1.54 | |
ROE | 0.33 | 1.78 | 1.1 | 0.62 | 0.59 | |
Capex per share | -2.94 | -1.45 | -2.24 | -2.07 | -2.75 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 7.21 | 7.71 | 7.68 | 7.33 | 9.24 | |
Net income per share | 1.06 | 1.61 | 2.04 | 1.42 | 1.96 | |
Operating cash flow per share | 0.91 | 2.43 | 1.66 | 1.82 | 0.7 | |
Free cash flow per share | 0.41 | 1.74 | 1.08 | 0.87 | -0.23 | |
Cash per share | 3.04 | 3.04 | 2.33 | 3.87 | 3.14 | |
Book value per share | 9.49 | 11.18 | 11.21 | 11.79 | 12.3 | |
Tangible book value per share | -3.03 | -0.94 | -0.53 | 0.14 | 0.19 | |
Share holders equity per share | 9.49 | 11.18 | 11.21 | 11.79 | 12.3 | |
Interest debt per share | 18.77 | 17.73 | 17.18 | 20 | 21.05 | |
Market cap | 289.14B | 295.22B | 348.31B | 325.55B | 420.9B | |
Enterprise value | 303.33B | 308.49B | 362.48B | 340.89B | 437.03B | |
P/E ratio | 75.89 | 50.84 | 44.94 | 60.52 | 59.68 | |
Price to sales ratio | 44.57 | 42.53 | 47.7 | 46.77 | 50.64 | |
POCF ratio | 352.31 | 135.12 | 220.49 | 188.12 | 666.09 | |
PFCF ratio | 782.09 | 188.69 | 340.12 | 393.61 | -2.06K | |
P/B Ratio | 33.84 | 29.32 | 32.71 | 29.09 | 38.04 | |
PTB ratio | 33.84 | 29.32 | 32.71 | 29.09 | 38.04 | |
EV to sales | 46.75 | 44.44 | 49.64 | 48.98 | 52.58 | |
Enterprise value over EBITDA | 145.81 | 128.43 | 151.49 | 200.05 | 188.38 | |
EV to operating cash flow | 369.6 | 141.2 | 229.46 | 196.98 | 691.61 | |
EV to free cash flow | 820.47 | 197.17 | 353.95 | 412.15 | -2.14K | |
Earnings yield | 0 | 0 | 0.01 | 0 | 0 | |
Free cash flow yield | 0 | 0.01 | 0 | 0 | 0 | |
Debt to equity | 1.97 | 1.58 | 1.52 | 1.69 | 1.7 | |
Debt to assets | 0.36 | 0.33 | 0.33 | 0.36 | 0.34 | |
Net debt to EBITDA | 6.82 | 5.52 | 5.92 | 9 | 6.95 | |
Current ratio | 1.1 | 1.13 | 1.05 | 1.3 | 1.13 | |
Interest coverage | 21.32 | 25.02 | 21.86 | 14.53 | 17.67 | |
Income quality | 0.86 | 1.5 | 0.82 | 1.29 | 0.36 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.93 | 0.61 | 0.46 | 0.76 | 0.58 | |
Sales general and administrative to revenue | 0.24 | 0.22 | 0.23 | 0.25 | 0.23 | |
Research and developement to revenue | 0.27 | 0.26 | 0.27 | 0.29 | 0.28 | |
Intangibles to total assets | 0.24 | 0.23 | 0.23 | 0.21 | 0.2 | |
Capex to operating cash flow | -0.55 | -0.28 | -0.35 | -0.52 | -1.32 | |
Capex to revenue | -0.07 | -0.09 | -0.08 | -0.13 | -0.1 | |
Capex to depreciation | -1.29 | -1.71 | -1.48 | -2.49 | -2.28 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
Graham number | 15.03 | 20.14 | 22.68 | 19.39 | 23.29 | |
ROIC | 0.06 | 0.07 | 0.06 | 0.04 | 0.06 | |
Return on tangible assets | 0.03 | 0.04 | 0.05 | 0.03 | 0.04 | |
Graham Net | -31.06 | -29.3 | -29.39 | -30.72 | -35.08 | |
Working capital | 1.49B | 1.99B | 896.3M | 4.8B | 2.42B | |
Tangible asset value | -2.73B | -849.8M | -504.2M | 134.7M | 166.9M | |
Net current asset value | -21.29B | -19.66B | -20.68B | -21.06B | -22.33B | |
Invested capital | 1.97 | 1.58 | 1.52 | 1.69 | 1.7 | |
Average receivables | 7.74B | 8B | 8.44B | 8.79B | 9.1B | |
Average payables | 1.55B | 1.67B | 1.81B | 1.97B | 2.25B | |
Average inventory | 3.9B | 3.87B | 4.07B | 4.43B | 4.67B | |
Days sales outstanding | 106.43 | 107.93 | 105.49 | 116.67 | 99.3 | |
Days payables outstanding | 104.39 | 95.93 | 112.24 | 111.53 | 123.2 | |
Days of inventory on hand | 245.33 | 218.35 | 250.55 | 251.45 | 238.95 | |
Receivables turnover | 0.85 | 0.83 | 0.85 | 0.77 | 0.91 | |
Payables turnover | 0.86 | 0.94 | 0.8 | 0.81 | 0.73 | |
Inventory turnover | 0.37 | 0.41 | 0.36 | 0.36 | 0.38 | |
ROE | 0.11 | 0.14 | 0.18 | 0.12 | 0.16 | |
Capex per share | -0.5 | -0.69 | -0.58 | -0.95 | -0.93 |
LLY.DE Frequently Asked Questions
What is Eli Lilly and Company stock symbol ?
Eli Lilly and Company is a US stock , located in Indianapolis of In and trading under the symbol LLY.DE
What is Eli Lilly and Company stock quote today ?
Eli Lilly and Company stock price is $517.5 today.
Is Eli Lilly and Company stock public?
Yes, Eli Lilly and Company is a publicly traded company.